Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,940Revenue $M7,435Net Margin (%)7.5Z-Score3.1
Enterprise Value $M14,539EPS $3.8Operating Margin %13.2F-Score6
P/E(ttm))20.0Cash Flow Per Share $5.2Pre-tax Margin (%)11.4Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %7.1Quick Ratio0.9Cash flow > EarningsY
Price/Sales1.55-y EBITDA Growth Rate %3.6Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow11.3y-y EBITDA Growth Rate %-22.4ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %1.8Insider Buy (3m)0ROE % (ttm)13.6Less Shares Outstanding y-yY
Payout Ratio %26.0Shares Outstanding M144ROI % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXBrian Rogers 2015-03-31 Reduce-0.3%$66.27 - $77.69
($71.61)
$ 75.816%Reduce -41.67%1,750,000
DGXCharles Brandes 2014-12-31 Buy 0.18%$57.71 - $68.1
($63.08)
$ 75.8117%New holding186,113
DGXRobert Olstein 2014-12-31 Reduce-0.18%$57.71 - $68.1
($63.08)
$ 75.8117%Reduce -28.05%59,000
DGXRichard Pzena 2014-12-31 Sold Out -0.14%$57.71 - $68.1
($63.08)
$ 75.8117%Sold Out0
DGXHOTCHKIS & WILEY 2014-12-31 Reduce-0.13%$57.71 - $68.1
($63.08)
$ 75.8117%Reduce -38.25%983,900
DGXJoel Greenblatt 2014-12-31 Reduce-0.09%$57.71 - $68.1
($63.18)
$ 75.8117%Reduce -62.94%88,219
DGXHOTCHKIS & WILEY 2014-09-30 Reduce-0.19%$59.28 - $64.08
($61.73)
$ 75.8119%Reduce -36.86%1,593,262
DGXJoel Greenblatt 2014-09-30 Add0.14%$59.28 - $64.08
($61.73)
$ 75.8119%Add 5330.13%238,057
DGXChris Davis 2014-06-30 Add0.8%$55.5 - $61.75
($58.56)
$ 75.8123%Add 4465.97%4,672,681
DGXRichard Pzena 2014-06-30 Reduce-0.18%$55.5 - $61.75
($58.56)
$ 75.8123%Reduce -55.66%431,100
DGXRobert Olstein 2014-06-30 Reduce-0.14%$55.5 - $61.75
($58.56)
$ 75.8123%Reduce -18.00%82,000
DGXJoel Greenblatt 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 75.8123%Reduce -94.26%4,384
DGXDavid Dreman 2014-06-30 Reduce-0.06%$55.5 - $61.75
($58.56)
$ 75.8123%Reduce -26.19%35,982
DGXJoel Greenblatt 2014-03-31 Reduce-0.26%$50.8 - $57.99
($53.53)
$ 75.8129%Reduce -72.63%76,412
DGXHOTCHKIS & WILEY 2014-03-31 Add0.1%$50.8 - $57.99
($53.53)
$ 75.8129%Add 23.69%2,495,500
DGXDavid Dreman 2014-03-31 Add0.09%$50.8 - $57.99
($53.53)
$ 75.8129%Add 66.84%48,748
DGXChris Davis 2014-03-31 Buy 0.02%$50.8 - $57.99
($53.53)
$ 75.8129%New holding102,337
DGXJoel Greenblatt 2013-12-31 Add0.3%$52.79 - $63.7
($59.36)
$ 75.8122%Add 533.63%279,188
DGXRichard Pzena 2013-12-31 Add0.17%$52.79 - $63.7
($59.36)
$ 75.8122%Add 81.17%1,215,050
DGXJohn Rogers 2013-12-31 Add0.15%$52.79 - $63.7
($59.36)
$ 75.8122%Add 447.73%268,053
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.165.69view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.744.84view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.415.32view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.975.97view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.343.97view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.433.84view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.884.63view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.55.19view
BONGIORNO THOMAS FVP and Corporate Controller 2014-11-18Sell10,000$6417.52view
Cohen Jon RSVP and Chief Medical Officer 2014-11-17Sell160,029$63.1319.14view

Press Releases about DGX :

    Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
    Charles Brandes' Top Buys During Q4 Feb 11 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
    Bernard Horn Comments on Quest Diagnostics Aug 07 2014 
    Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
    Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 


    More From Other Websites
    Quest Diagnostics (DGX) Earnings Report: Q1 2015 Conference Call Transcript Apr 24 2015
    Quest Diagnostics Finds Path to Upside Apr 24 2015
    Quest Diagnostics (DGX) Tops Q1 Earnings, Keeps '15 View - Analyst Blog Apr 23 2015
    Quest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today Apr 23 2015
    Quest Diagnostics Revenue Rises Apr 23 2015
    Quest Diagnostics beats 1Q profit forecasts Apr 23 2015
    Quest Diagnostics beats 1Q profit forecasts Apr 23 2015
    7:15 am Quest Diagnostics beats by $0.01, reports revs in-line; reaffirms FY15 EPS in-line, revs... Apr 23 2015
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 23 2015
    Q1 2015 Quest Diagnostics Inc Earnings Release - Before Market Open Apr 23 2015
    Quest Diagnostics Reports First Quarter 2015 Financial Results Apr 23 2015
    German lab group Synlab hoping for industry consolidation Apr 22 2015
    Will Quest Diagnostics' (DGX) Earnings Surprise in Q1? - Analyst Blog Apr 22 2015
    German lab group Synlab hoping for industry consolidation Apr 22 2015
    German lab group Synlab hoping for industry consolidation Apr 22 2015
    LabCorp joins international breast cancer research initiative Apr 21 2015
    BC Partners launches sale of German lab group Synlab - sources Apr 21 2015
    BC Partners launches sale of German lab group Synlab - sources Apr 21 2015
    BC Partners launches sale of German lab group Synlab - sources Apr 21 2015
    Hunt for Deadly Breast Cancer Genes Pools Thousands of Women Apr 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK